Large-scale Metabolomic Profiling Identifies Novel Biomarkers for Incident Coronary Heart Disease

PLoS Genetics

Volumn 10, Issue 12, 2014, Pages

  Ganna, Andrea ^a   Salihovic, Samira ^b   Sundström, Johan ^b   Broeckling, Corey D ^c   Hedman, Åsa K ^b   Magnusson, Patrik K E ^a   Pedersen, Nancy L ^a   Larsson, Anders ^b   Siegbahn, Agneta ^b   Zilmer, Mihkel ^d   Prenni, Jessica ^c   Ärnlöv, Johan ^b,e   Lind, Lars ^b   Fall, Tove ^b   Ingelsson, Erik ^b,f  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d Faculty of Medicine   (Estonia)

^e DALARNA UNIVERSITY   (Sweden)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LYSOPHOSPHATIDYLCHOLINE; MONOACYLGLYCEROL; SPHINGOMYELIN; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLOMICS; OXIDATIVE STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CORONARY DISEASE; GENE EXPRESSION PROFILING; GENETICS; INCIDENCE; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SWEDEN;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HUMANS; INCIDENCE; LINEAR MODELS; LONGITUDINAL STUDIES; LYSOPHOSPHATIDYLCHOLINES; MALE; METABOLOMICS; MIDDLE AGED; MONOGLYCERIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SPHINGOMYELINS; SWEDEN;

EID: 84919639764     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004801     Document Type: Article

References (33)

1. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, et al. (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477: 54–60.
2. Magnusson M, Lewis GD, Ericson U, Orho-Melander M, Hedblad B, et al. (2013) A diabetes-predictive amino acid score and future cardiovascular disease. Eur Heart J 34: 1982–1989.
3. Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, et al. (2010) Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 3: 207–214.
4. Boyanovsky BB, Webb NR, (2009) Biology of secretory phospholipase A2. Cardiovasc Drugs Ther 23: 61–72.
5. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837–1847.
6. Lemaitre RN, Tanaka T, Tang W, Manichaikul A, Foy M, et al. (2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. PLoS Genet 7: e1002193.
7. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333–338.
8. Demirkan A, van Duijn CM, Ugocsai P, Isaacs A, Pramstaller PP, et al. (2012) Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genet 8: e1002490.
9. Deloukas P, Kanoni S, Willenborg C, Farrall M, CARDIoGRAMplusC4D Consortium (2013) et al. (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45: 25–33.
10. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, et al. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123: 2292–2333.
11. Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, et al. (2013) Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet 45: 1345–1352.
12. Rozenberg O, Shih DM, Aviram M, (2003) Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation. Arterioscler Thromb Vasc Biol 23: 461–467.
13. Gauster M, Rechberger G, Sovic A, Horl G, Steyrer E, et al. (2005) Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. J Lipid Res 46: 1517–1525.
14. Sekas G, Patton GM, Lincoln EC, Robins SJ, (1985) Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. J Lab Clin Med 105: 190–194.
15. Shamburek RD, Zech LA, Cooper PS, Vandenbroek JM, Schwartz CC, (1996) Disappearance of two major phosphatidylcholines from plasma is predominantly via LCAT and hepatic lipase. Am J Physiol 271: E1073–1082.
16. Schmitz G, Ruebsaamen K, (2010) Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 208: 10–18.
17. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, et al. (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 8: 615.
18. Fernandez C, Sandin M, Sampaio JL, Almgren P, Narkiewicz K, et al. (2013) Plasma lipid composition and risk of developing cardiovascular disease. PLoS One 8: e71846.
19. Stegemann C, Pechlaner R, Willeit P, Langley S, Mangino M, et al. (2014) Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study. Circulation
20. Tzoulaki I, Ebbels TM, Valdes A, Elliott P, Ioannidis JP, (2014) Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies. Am J Epidemiol 180: 129–139.
21. Ganna A, Fall T, Lee W, Broeckling CD, Kumar J, et al. (2014) A workflow for UPLC-MS non-targeted metabolomic profiling in large human population-based studies. bioRxiv
22. Ganna A, Lee D, Ingelsson E, Pawitan Y, (2014) Rediscovery rate estimation for assessing the validation of significant findings in high-throughput studies. Brief Bioinform
23. Magnusson PK, Almqvist C, Rahman I, Ganna A, Viktorin A, et al. (2013) The Swedish Twin Registry: establishment of a biobank and other recent developments. Twin Res Hum Genet 16: 317–329.
24. Ganna A, Reilly M, de Faire U, Pedersen N, Magnusson P, et al. (2012) Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol 175: 715–724.
25. Byberg L, Siegbahn A, Berglund L, McKeigue P, Reneland R, et al. (1998) Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men. Arterioscler Thromb Vasc Biol 18: 258–264.
26. Lind L, Fors N, Hall J, Marttala K, Stenborg A, (2005) A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler Thromb Vasc Biol 25: 2368–2375.
27. Broeckling CD, Heuberger AL, Prenni JE, (2013) Large scale non-targeted metabolomic profiling of serum by ultra performance liquid chromatography-mass spectrometry (UPLC-MS). J Vis Exp e50242.
28. Lind L, Fors N, Hall J, Marttala K, Stenborg A, (2006) A comparison of three different methods to determine arterial compliance in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. J Hypertens 24: 1075–1082.
29. Lind L, Siegbahn A, Hulthe J, Elmgren A, (2008) C-reactive protein and e-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the prospective investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 199: 129–137.
30. Lind L, Siegbahn A, Ingelsson E, Sundstrom J, Arnlov J, (2011) A detailed cardiovascular characterization of obesity without the metabolic syndrome. Arterioscler Thromb Vasc Biol 31: e27–34.
31. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G, (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78: 779–787.
32. Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, et al. (2007) Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3: 211–221.
33. Leening MJ, Vedder MM, Witteman JC, Pencina MJ, Steyerberg EW, (2014) Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann Intern Med 160: 122–131.